FindTrial
Sign In

aCRT ON

DEVICE2 trials

Sponsors

Medtronic Cardiac Rhythm and Heart Failure

Conditions

Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IVHeart Failure With Left Bundle Branch BlockHeart Failure With Reduced Ejection Fraction (HFrEF)Left Bundle-Branch Block

Unknown Phase

AdaptResponse Clinical Trial
CompletedNCT02205359
Medtronic Cardiac Rhythm and Heart FailureHeart Failure With Left Bundle Branch Block
Start: 2014-08-31End: 2022-11-02Updated: 2023-11-29
Mid-Q Response Study
CompletedNCT04180696
Medtronic Cardiac Rhythm and Heart FailureHeart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III +3
Start: 2020-01-23End: 2024-03-28Updated: 2025-07-09

Related Papers

Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
2023-08-2437 citations
Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.
2017-07-0128 citations